Millions of rapid COVID-19 tests that will be distributed for free by the Trump administration are not clinically approved for large-scale testing of the general population. Rather, Abbott Labs’ BinaxNow antigen test received emergency Food and Drug Administration approval for people showing symptoms of the disease. So, how will they be used in New Jersey? Senior Correspondent Brenda Flanagan reports.
Views expressed by our advertisers and sponsors are their own, and are not endorsed by NJ Spotlight News.